pipette
ESEspañol

Polycomb factor PHF19 affects AML initiation, patient prognosis, and survival

Gianni Paolo Gamarra Figueroa, Arantxa Gutiérrez, Enrique Blanco, Pedro Vizán, Cecilia Ballaré, Aleksandra Sparavier, Marta Tosto, Saverio Minucci, Lars Velten, Luciano Di Croce

Peer-reviewed journalBold claims, read critically

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
From these data, we derived a prognostic signature—PHFScore—which reveals previously unrecognized AML survival-correlating genes that robustly stratify patients across distinct cellular origins and leukemogenic stages, underscoring Phf19’s key role in AML biology and prognosis.

Appeared: Sunday, October 25. Science Advances. Peer-reviewed journal.

DOI: 10.1126/sciadv.aed6757